The Department of Pathology and Laboratory Medicine of the Medical University of South Carolina offers a fully accredited training program in anatomic and clinical pathology (AP/CP). The AP/CP program consists of a 39 month core curriculum with 9 months of elective. Anatomic Pathology core rotations include autopsy pathology/forensic pathology, surgical pathology, cytopathology, dermatopathology and VA pathology. Clinical Pathology core rotations include hematopathology, immunopathology, clinical chemistry, microbiology, tranfusion medicine, apharesis, histocompatibility laboratory, molecular pathology, cytogenetics, VA pathology, laboratory management and informatics. Nine months elective time is available for more in-depth studies in areas of special interest and/or research. Training programs for certification eligibility in anatomic pathology or clinical pathology are available and structured on an individual basis. A graduate (PhD) program in experimental pathology is available and may be coordinated with the residency training program. Fellowships are offered at the discretion of the Chair in forensic pathology, dermatopathology, cytopathology, surgical pathology, hematopathology and clinical chemistry.
Types and Numbers of Appointments
The institution is accredited for twenty-two residency positions in anatomic pathology and clinical pathology, with an even distribution of residents at all levels. Persons seeking the PhD degree in experimental pathology must meet the requirements of the College of Graduate Studies, Medical University of South Carolina. The department participates in the electronic residency application service (ERAS). The deadline for residency application is by November 1st the year prior to entrance.
The MUSC Teaching Hospital System and the Charleston VA provide the pathology training program with an abundance of clinical material. Yearly figures (2011) are: 120 medical autopsies; 670 forensic autopsies; 28,699 surgical pathology (including neuropathology and dermatopathology specimens); 21,040 cytology specimens (14,479 pap smears, 3,683 exfoliative cytology, 2,804 fine needle aspirations); 197 diagnostic electron microscopic procedures; and 100 tissue immunofluorescent procedures (kidney, heart and skin). The Division of Laboratory Medicine performs approximately 3,314,871 clinical pathology tests, including transfusion medicine 132,751; HLA 26,231; chemistry/hematology 2,986,117; cytogenetics 2,135, with karyotypes, 1374, and an additional 658 FISH tests; and microbiological 162,631. In addition, an active apheresis unit is located in the Department of Nephrology. In Hemapheresis Services, 2,974 procedures were performed in 2011, including therapeutic plasma exchange, red blood cell exchange, hematopoietic progenitor cell collection from autologous and allogeneic donors, cell depletion, and therapeutic phlebotomy. The Divisions of Anatomic Pathology and Laboratory Medicine are housed primarily on the second and third floors of the Children's Hospital, with additional space located in Hollings Cancer Center, Rutledge Tower (outpatient facility), Ashley River Tower (GI and Cardiovascular) facility, and the Medical University Hospital. In excess of 55,000 square feet are dedicated to the two divisions.
Besides the Colleges of Medicine, Pharmacy, Dentistry, Nursing, Health Related Professions, and Graduate Studies of the Medical University of South Carolina, educational institutions in Charleston include the College of Charleston, Charleston Southern University, The Citadel Military College, Trident Technical College and several business colleges. This progressive historic seaport city offers its own symphony orchestra and ballet companies, choral and theater groups and outstanding recreational areas to 552,803 persons in the metropolitan area. Historic homes, plantations, gardens, access to the intracoastal waterway, beaches and year-round fresh and salt-water fishing, sailing, surfing, golfing, etc, which draws thousands of tourists yearly, are within minutes of the medical center.
Annual stipends are from $45,932 upward. Interns and residents are provided individual office space, computer, microscope, equipment and parking. Malpractice insurance is provided.
Nicholas Batalis MD, forensic pathology and medical autopsy; Michael Caplan MD, pediatric pathology, medical autopsy; Christina Carrick MD, surgical pathology; Haytham Dimashkieh MD, surgical pathology, cytopathology; Stephen Ethier PhD, Co-leader in cancer genetics and molecular regulation program; breast cancer biology and cancer genomics; Weimin Fan MD, molecular tumor biology; Victoria J Findlay PhD, role of microRNAs during cancer progression; Yong-Zhong Gong MD, xenograft facility; Debra Hazen-Martin PhD, electron microscopy and freeze fracture; Toshihiko Kawamori MD, PhD, MIAC experimental pathology, chemoprevention of colon cancer; Janice M. Lage MD, Chair, Pathology and Laboratory Medicine; obstetrics/gynecologic, perinatal, breast pathology; Hainan Lang MD, PhD, auditory physiology, cell biology of hearing and deafness; Amanda C LaRue PhD, tissue reconstitution potential of hematopoietic stems cells; John Lazarchick MD, Director of Hematopathology; platelet disorders, lymphoproliferative disorders - T & B cell lymphoma, hemophilia A; David N. Lewin MD, Director Residency Training Program; surgical pathology, gastrointestinal pathology, hepatopathology; James E. Madory DO, surgical pathology, pathology informatics, and gynecologic pathology; Becky Madory MD, surgical pathology, cytopathology, VA lab services; Ana Maria Medina MD, cytopathology, hematopathology, surgical pathology; John S. Metcalf MD, Vice Chair, Pathology and Laboratory Medicine; surgical pathology and dermatopathology; Omar Moussa PhD, Director, HLA Laboratory; bladder cancer, molecular pathology, transplantation immunology; Frederick S Nolte PhD., Director, Clinical Laboratories; medical microbiology, molecular diagnostics, point-of-care testing, laboratory management; Makio Ogawa MD, PhD, cellular physiology of hematopoietic cells; S. Erin Presnell MD, Director, forensic pathology; medical autopsy; Jon Ralston MD, Dermatopathology and surgical pathology; Mary S. Richardson MD, DDS, Director, Surgical Pathology; gynecologic and ENT pathology; Ellen Riemer MD, Autopsy and forensic pathology, pulmonary pathology; Tihana Rumboldt MD, surgical pathology, breast pathology, head and neck pathology; Cynthia Schandl MD, PhD, Autopsy and forensic pathology; Bradley A. Schulte PhD, Director, Research; experimental pathology; Sally E. Self MD, Director, Diagnostic Immunology; immunopathology, renal pathology; Avtar K. Singh MD, hematopathology, VA lab services; M. Timothy Smith MD, Director, Anatomic Pathology; surgical pathology, neuropathology, dermatopathology, cytopathology; Demetri D. Spryropoulous PhD, hox and ets transcription factors in development and cancer; Jerry E Squires MD, PhD Director of Transfusion Services; Lisa L. Steed PhD, Director, Diagnostic Microbiology; David P Turner PhD, aberrant expression of cancer associated genes in transcriptional regulatory networks; Yong Wang MD, PhD cancer stem cells, aging; Dennis Watson PhD, molecular biology of gene regulation, molecular genetics of cancer; Cynthia T. Welsh MD, Director, Neuropathology; surgical pathology, neuropathology, pediatric pathology, cytopathology; Daynna J. Wolff PhD, Director, Cytogenetics and Molecular Genetics; Je-Seong Won PhD, neuroinflammation, neurodegenerative disease; Julie Woolworth PhD, Molecular pathology; Jack Yang MD, Director, Cytopathology, fine needle aspirates, surgical pathology; Yusheng Zhu PhD, Director of Clinical Chemistry; toxicology, pharmacogenomics.
Address inquiries to:
|Copyright 2011 MUSC Department of Pathology and Laboratory Medicine|